Together, we’re at one of the most important moments in healthcare. You’re preparing for the future in the face of new realities, and we’re with you with smart and connected systems, optimized workflows and insights generated by integrated diagnostics. Join us for the future of advanced molecular imaging, which leads to the right care pathways with predictable outcomes for every patient.
Join us for our latest symposium
Together, we’re at one of the most important moments in healthcare. Join us in this satellite symposium to see how we are able to reduce the patient dose for F-18 FDG on a Vereos PET-CT system by tuning the reconstruction parameters.
Optimization of F-18 FDG dose in a Vereos PET-CT system Monday October 26, 2020 12:20 – 13:40 CET
Jan-Willem Postema, Dr. (Nuclear Medicine Physician), Reinier de Graaf Gasthuis
Vincent Verhoeven, Ph.D. (Medical Physicist), Reinier de Graaf Gasthuis
Familiarize yourself with the world’s first and only fully digital, clinically proven PET/CT solution, with proprietary Digital Photon Counting technology for outstanding advances all along the imaging chain.
Your diagnosis depends on the details, and we’re with you in every defining moment. The world’s first digital PET scanner uses proprietary Digital Photon Counting (DPC) technology to convert light directly to a digital signal with zero analog noise for clinically proven accuracy.
We’re with you as you streamline workflows across your hospital, with one work environment, one advanced imaging solution. This is a rich portfolio with clinical depth, secure image access and enterprise management that’s on a constantly updating platform.
By clicking on the link, you will be leaving the official Royal Philips Healthcare ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.